Form 4: Hims & Hers Health COO Melissa Baird Reports Stock Transactions
SEC Form 4
Chief Operating Officer of Hims & Hers Health, Melissa Baird, reports the acquisition and disposal of company stock and restricted stock units.
Summary
- Melissa Baird, the Chief Operating Officer of Hims & Hers Health, reported transactions involving the company's Class A Common Stock and Restricted Stock Units (RSUs).
- On December 13, 2024, Baird acquired 73,146 shares of Class A Common Stock through the vesting of RSUs.
- Also on December 13, 2024, 28,778 shares were disposed of to cover tax obligations at a price of $30.02 per share.
- Baird also acquired various tranches of RSUs, totaling 65,046, which vest over a four-year period in quarterly installments.
- Following these transactions, Baird directly owns 675,354 shares of Class A Common Stock and 639,909 RSUs.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document primarily reports routine stock transactions by an executive. There are no indications of significant positive or negative events.
Positives
- The vesting of RSUs indicates that Baird is meeting the service-based requirements of her employment.
- The acquisition of shares through RSU vesting increases Baird's stake in the company.
Negatives
- The disposal of 28,778 shares to cover tax obligations reduces Baird's overall shareholding.
Risks
- Fluctuations in the stock price could impact the value of Baird's holdings.
- Future vesting of RSUs is contingent on continued service with the company.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the stock ownership of key executives.
Comparison to Industry Standards
- The reporting of stock transactions by executives is a standard practice for publicly traded companies, such as Hims & Hers Health, and is comparable to similar filings by executives at companies like Teladoc Health (TDOC) and GoodRx (GDRX).
- The vesting schedules for RSUs are also typical, with four-year vesting periods being common in the tech and healthcare industries.
Stakeholder Impact
- The transactions may have a minor impact on shareholders as they reflect changes in insider ownership.
- The vesting of RSUs could be seen as a positive sign for employees as it indicates the company is meeting its obligations.
Key Dates
| Date | Description |
|---|---|
| 12/13/2024 | Date of stock and RSU transactions. |
| 12/17/2024 | Date of filing the SEC Form 4. |
Keywords
Hims & Hers Health, Melissa Baird, Class A Common Stock, Restricted Stock Units, RSU, Stock Transactions, Insider Trading, SEC Form 4, Chief Operating Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.